BioProcess International is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Lintao Wang is currently the Associate Director in Analytical and Pharmaceutical Science (APS) at ImmunoGen. His areas of expertise include analytical and bioanalytical development and mass spectrometric analysis of proteins and small-molecule compounds. Dr. Wang received his B.S. & M.S. degrees in Beijing University. In 2002 he graduated with Ph.D. in Chemistry from University of Nebraska-Lincoln (UNL) and Midwest Center for Mass Spectrometry (MCMS). He joined ImmunoGen in 2002 and started his career in developing anticancer immunotherapies such as antibody-drug conjugates (ADC). In 2007, he joined Shire as a senior scientist for tandem MS method development in Bioanalytical and Biomarker Development. In 2011, he rejoined ImmunoGen as the group leader for Mass Spec as well as the high throughput analytics. He supported ADC programs at all stages from early antibody cell line screening to late-stage in-depth structural characterization. Overall, with ~20 years of experience in protein analytics and a number of publications and conference presentations, Dr. Wang is a well-established analytical chemist in the antibody and ADC development of the biopharma/biotech industry.